Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Krystal Biotech Inc.

    NASDAQ: KRYS · Real-Time Price · USD
    132.54
    0.51 (0.39%)
    At close: Jun 05, 2025, 3:59 PM
    133.68
    0.86%
    After-hours: Jun 05, 2025, 07:52 PM EDT

    Krystal Biotech Statistics

    Share Statistics

    Krystal Biotech has 28.9M shares outstanding. The number of shares has increased by 0.87% in one year.

    Shares Outstanding

    n/a
    		 28.9M

    Shares Change (YoY)

    n/a
    		 0.87%

    Shares Change (QoQ)

    n/a
    		 0.16%

    Owned by Institutions (%)

    n/a
    		 96.69%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 2.6M, so 9% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.6M

    Short % of Shares Out

    n/a
    		 9%

    Short % of Float

    n/a
    		 15.1%

    Short Ratio (days to cover)

    n/a
    		 5.33

    Valuation Ratios

    The PE ratio is 50.24 and the forward PE ratio is 15.15. Krystal Biotech's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 50.24

    Forward PE

    n/a
    		 15.15

    PS Ratio

    n/a
    		 15.42

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 4.73

    P/FCF Ratio

    n/a
    		 37.58

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Krystal Biotech has an Enterprise Value (EV) of 4.14B.

    EV / Sales

    n/a
    		 14.26

    EV / EBITDA

    n/a
    		 37.68

    EV / EBIT

    n/a
    		 33.56

    EV / FCF

    n/a
    		 34.75

    Financial Position

    The company has a current ratio of 7.28, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 7.28

    Quick Ratio

    n/a
    		 7.02

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 0.07

    Debt / FCF

    n/a
    		 0.06

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 9.42% and Return on Invested Capital is 6.43%.

    Return on Equity

    n/a
    		 9.42%

    Return on Assets

    n/a
    		 8.44%

    Return on Invested Capital

    n/a
    		 6.43%

    Revenue Per Employee

    n/a
    		 $1,056,418.18

    Profits Per Employee

    n/a
    		 $324,214.55

    Employee Count

    n/a
    		 275

    Asset Turnover

    n/a
    		 0.28

    Inventory Turnover

    n/a
    		 0.76

    Taxes

    Income Tax

    n/a
    		 6.2M

    Effective Tax Rate

    n/a
    		 6.5%

    Stock Price Statistics

    The stock price has increased by -20.72% in the last 52 weeks. The beta is 0.66, so Krystal Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.66

    52-Week Price Change

    n/a
    		 -20.72%

    50-Day Moving Average

    n/a
    		 154.03

    200-Day Moving Average

    n/a
    		 170.64

    Relative Strength Index (RSI)

    n/a
    		 42.15

    Average Volume (20 Days)

    n/a
    		 339,269

    Income Statement

    In the last 12 months, Krystal Biotech had revenue of 290.51M and earned 89.16M in profits. Earnings per share was 3.12.

    Revenue

    n/a
    		 290.51M

    Gross Profit

    n/a
    		 270.45M

    Operating Income

    n/a
    		 65.69M

    Net Income

    n/a
    		 89.16M

    EBITDA

    n/a
    		 109.91M

    EBIT

    n/a
    		 103.19M

    Earnings Per Share (EPS)

    n/a
    		 3.12
    Full Income Statement

    Balance Sheet

    The company has 344.87M in cash and 7.26M in debt, giving a net cash position of 337.6M.

    Cash & Cash Equivalents

    n/a
    		 344.87M

    Total Debt

    n/a
    		 7.26M

    Net Cash

    n/a
    		 337.6M

    Retained Earnings

    n/a
    		 -180.67M

    Total Assets

    n/a
    		 1.07B

    Working Capital

    n/a
    		 687.31M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 123.42M and capital expenditures -4.24M, giving a free cash flow of 119.18M.

    Operating Cash Flow

    n/a
    		 123.42M

    Capital Expenditures

    n/a
    		 -4.24M

    Free Cash Flow

    n/a
    		 119.18M

    FCF Per Share

    n/a
    		 4.17
    Full Cash Flow Statement

    Margins

    Gross margin is 93.09%, with operating and profit margins of 22.61% and 30.69%.

    Gross Margin

    n/a
    		 93.09%

    Operating Margin

    n/a
    		 22.61%

    Pretax Margin

    n/a
    		 32.82%

    Profit Margin

    n/a
    		 30.69%

    EBITDA Margin

    n/a
    		 37.83%

    EBIT Margin

    n/a
    		 22.61%

    FCF Margin

    n/a
    		 41.02%

    Dividends & Yields

    KRYS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.99%

    FCF Yield

    n/a
    		 2.66%
    Dividend Details

    Analyst Forecast

    The average price target for KRYS is $219, which is 64.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $219

    Price Target Difference

    n/a
    		 64.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 48.19

    Graham Upside

    n/a
    		 -63.74%

    Scores

    Altman Z-Score

    n/a
    		 25.66

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist